tiprankstipranks
Chromocell Therapeutics Corp (CHRO)
NYSE MKT:CHRO
US Market

Chromocell Therapeutics Corp (CHRO) Technical Analysis

8 Followers

Technical Sentiment

Overall Consensus
Strong Sell
3Bullish
4Neutral
13Bearish
Technical Analysis Consensus
Neutral
3Bullish
4Neutral
3Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
10Bearish
Chromocell Therapeutics Corp’s (CHRO) Moving Averages Convergence Divergence (MACD) indicator is -0.09, suggesting Chromocell Therapeutics Corp is a Sell.
Chromocell Therapeutics Corp’s (CHRO) 20-Day exponential moving average is 1.29, while Chromocell Therapeutics Corp’s (CHRO) share price is $1.19, making it a Sell.
Chromocell Therapeutics Corp’s (CHRO) 50-Day exponential moving average is 1.56, while Chromocell Therapeutics Corp’s (CHRO) share price is $1.19, making it a Sell.

Chromocell Therapeutics Corp (CHRO) Pivot Points

Jul 17, 2024, 05:35 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.93
1.01
1.08
1.16
1.23
1.31
1.38
Fibonacci
1.01
1.07
1.10
1.16
1.22
1.25
1.31
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Chromocell Therapeutics Corp (CHRO) Moving Averages

Jul 17, 2024, 05:35 PM
Period
Simple
Exponential
MA5
1.21Sell
1.20Sell
MA10
1.21Sell
1.23Sell
MA20
1.30Sell
1.29Sell
MA50
1.50Sell
1.56Sell
MA100
2.10Sell
2.12Sell
Chromocell Therapeutics Corp’s (CHRO) 10-Day exponential moving average is 1.23, while Chromocell Therapeutics Corp’s (CHRO) share price is $1.19, making it a Sell.
Chromocell Therapeutics Corp’s (CHRO) 100-Day exponential moving average is 2.12, while Chromocell Therapeutics Corp’s (CHRO) share price is $1.19, making it a Sell.
Chromocell Therapeutics Corp’s (CHRO) stock price is $1.19 and Chromocell Therapeutics Corp’s (CHRO) 50-day simple moving average is 1.50, creating a Sell signal.
Chromocell Therapeutics Corp’s (CHRO) stock price is $1.19 and Chromocell Therapeutics Corp’s (CHRO) 100-day simple moving average is 2.10, creating a Sell signal.

Chromocell Therapeutics Corp (CHRO) Technical Indicators

Jul 17, 2024, 05:35 PM
Name
Value
Implied Action
RSI (14)
43.03
Neutral
STOCH (9,6)
31.75
Neutral
STOCHRSI (14)
27.21
Neutral
MACD (12,26)
-0.09
Sell
ADX (14)
15.78
Buy
Williams %R
-77.55
Buy
CCI (14)
-104.03
Buy
ATR (14)
0.16
-
Ultimate Oscillator
38.87
Neutral
ROC
-22.00
Sell
Chromocell Therapeutics Corp’s (CHRO) Relative Strength Index (RSI) is 43.03, creating a Neutral signal.
Chromocell Therapeutics Corp’s (CHRO) Trend Strength Indicator (ADX) is 15.78, creating a Buy signal.
Chromocell Therapeutics Corp’s (CHRO) Commodity Channel Index (CCI) is -104.03, creating a Buy signal.
Chromocell Therapeutics Corp’s (CHRO) Price Rate of Change (ROC) is -22.00, creating a Sell signal.

FAQ

Is CHRO a Buy, Hold, or Sell?
Based on CHRO’s technical indicators, CHRO is a Strong Sell.
    What is CHRO’s RSI (14)?
    CHRO’s RSI (14) is 43.03, which suggests CHRO is a Neutral.
      What is CHRO’s MACD?
      CHRO’s MACD is -0.09, which suggests CHRO is a Sell.
        What is CHRO’s 5-day moving average?
        CHRO’s 5-day moving average is 1.21, which suggests CHRO is a Sell.
          What is CHRO’s 20-day moving average?
          CHRO 20-day moving average is 1.30, which suggests CHRO is a Sell.
            What is CHRO’s 50-day moving average?
            CHRO’s 50-day moving average is 1.50, which suggests CHRO is a Sell.
              What is CHRO’s 200-day moving average?
              Currently, no data Available
              What is CHRO’s Williams % R (14)?
              CHRO’s Williams % R (14) is -77.55, which suggests CHRO is a Buy.
                What is CHRO’s CCI (14)?
                CHRO’s CCI (14) is -104.03, which suggests CHRO is a Buy.
                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis